search
Back to results

Aerobic Exercise for Primary Dysmenorrhea

Primary Purpose

Primary Dysmenorrhea

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
High-intensity aerobic training
Wait-list control
Sponsored by
The Hong Kong Polytechnic University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Primary Dysmenorrhea focused on measuring Dysmenorrhea, Primary dysmenorrhea, Pain, Absenteeism, Academic performance

Eligibility Criteria

18 Years - 24 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • women in the age group of 18-24 years old;
  • non-pregnant;
  • having regular menstrual cycles with cycle lengths between 24 and 30 days;
  • experiencing an average menstrual pain intensity equal to or greater than 5 on a 0-10 Numerical Rating Scale; and
  • scoring low (< 600 metabolic equivalent tasks [MET]/week) on the short-form of the International Physical Activity Questionnaire.

Exclusion Criteria:

  • women using oral contraceptive pills, hormonal therapy, or intrauterine devices;
  • women using over-the counter analgesics during menstruation to treat dysmenorrhea-associated pain and experience no pain relief with those analgesics; and
  • women participating in any formal exercise programme

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    High-intensity aerobic training (HIAT)

    Wait-list control (WLC)

    Arm Description

    Women will perform treadmill-based aerobic exercise for three days a week, at 70%-85% of MHR for 30 minutes and perceived exertion of 14-16, based on the Borg RPE scale. This range39 is considered to represent HIAT. Aerobic training will be preceded by warm-up exercises for 10 minutes and followed by cool-down exercises for 10 minutes, at a perceived exertion of 11.0 (Borg RPE).

    Women in the wait-list control group will be instructed to continue with their usual activities and manage their pain as normal (i.e., with analgesics).

    Outcomes

    Primary Outcome Measures

    Pain intensity
    Average pain intensity during the last 24 hours during menstruation will be assessed using the 0-10 Numeric Rating Scale, with 0 representing 'No pain' and 10 representing 'Worst imaginable pain'. Higher scores indicate greater pain severity
    Pain intensity
    Average pain intensity during the last 24 hours during menstruation will be assessed using the 0-10 Numeric Rating Scale, with 0 representing 'No pain' and 10 representing 'Worst imaginable pain'. Higher scores indicate greater pain severity
    Pain intensity
    Average pain intensity during the last 24 hours during menstruation will be assessed using the 0-10 Numeric Rating Scale, with 0 representing 'No pain' and 10 representing 'Worst imaginable pain'. Higher scores indicate greater pain severity
    Absenteeism from university
    A prospective electronic diary will be provided for each participant to record university absenteeism.
    Absenteeism from university
    A prospective electronic diary will be provided for each participant to record university absenteeism.
    Absenteeism from university
    A prospective electronic diary will be provided for each participant to record university absenteeism.
    Academic performance
    Academic performance will be measured using the self-reported 20-item academic performance questionnaire, which was developed to measure the impacts of menstrual symptoms on academic performance. Greater scores indicate greater severity of primary dysmenorrhea
    Academic performance
    Academic performance will be measured using the self-reported 20-item academic performance questionnaire, which was developed to measure the impacts of menstrual symptoms on academic performance. Greater scores indicate greater severity of primary dysmenorrhea
    Academic performance
    Academic performance will be measured using the self-reported 20-item academic performance questionnaire, which was developed to measure the impacts of menstrual symptoms on academic performance. Greater scores indicate greater severity of primary dysmenorrhea
    Progesterone levels
    Salivary levels of progesterone.
    Progesterone levels
    Salivary levels of progesterone.
    Progesterone levels
    Salivary levels of progesterone.
    Prostaglandin F2-alpha levels
    Salivary levels of prostaglandin F2-alpha
    Prostaglandin F2-alpha levels
    Salivary levels of prostaglandin F2-alpha
    Prostaglandin F2-alpha levels
    Salivary levels of prostaglandin F2-alpha

    Secondary Outcome Measures

    Concentration
    The 0-10 visual analogue scale will be used to measure the impact of dysmenorrhea on concentration, with 0 representing 'No difficulty concentrating' and 10 representing 'Maximum difficulty concentrating'.
    Concentration
    The 0-10 visual analogue scale will be used to measure the impact of dysmenorrhea on concentration, with 0 representing 'No difficulty concentrating' and 10 representing 'Maximum difficulty concentrating'.
    Concentration
    The 0-10 visual analogue scale will be used to measure the impact of dysmenorrhea on concentration, with 0 representing 'No difficulty concentrating' and 10 representing 'Maximum difficulty concentrating'.
    Dysmenorrhea daily diary
    dysmenorrhea. A higher score indicates worse pain.
    Dysmenorrhea daily diary
    The Dysmenorrhea daily diary is a questionnaire to measure the severity of dysmenorrhea. A higher score indicates worse pain.
    Dysmenorrhea daily diary
    dysmenorrhea. A higher score indicates worse pain.
    3-level version of EuroQol 5-Dimension
    The 3-level version of EuroQol 5-Dimension will be used to determine the quality of life. A higher score indicates better quality of life.
    Cost-diary
    An electronic diary will be used to record cost expenditures in Hong Kong Dollars and work absenteeism

    Full Information

    First Posted
    November 25, 2020
    Last Updated
    December 7, 2020
    Sponsor
    The Hong Kong Polytechnic University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04665661
    Brief Title
    Aerobic Exercise for Primary Dysmenorrhea
    Official Title
    Aerobic Exercise for Primary Dysmenorrhea: A Mixed-methods Study and Economic Evaluation
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2020
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 1, 2021 (Anticipated)
    Primary Completion Date
    August 31, 2024 (Anticipated)
    Study Completion Date
    August 31, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    The Hong Kong Polytechnic University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    Primary dysmenorrhea is common and can result in significant disability for many women, causing a high degree of discomfort and reduced quality of life (QoL). Our preliminary studies suggested that high-intensity aerobic training (HIAT) for 30 minutes, three times a week at 70%-85% of maximum heart rate was effective for decreasing pain and improving QoL in women suffering from primary dysmenorrhea. However, to date, no studies have evaluated the beneficial effects of HIAT on academic performance and absenteeism or the cost-effectiveness of HIAT for women with primary dysmenorrhea. Furthermore, the mechanisms underlying aerobic exercise-induced analgesia in primary dysmenorrhea remain unclear. Here, we propose a study to address this important knowledge gap by investigating the effects of HIAT on absenteeism and academic performance among university students with primary dysmenorrhea and examine the physiological mechanisms underlying aerobic exercise-induced analgesia by conducting a fully powered, randomised, controlled crossover trial. We also propose to conduct an economic evaluation to determine the cost-effectiveness of HIAT compared with a wait-listed control group receiving usual care, according to the societal and healthcare perspectives of Hong Kong. The results of this cutting-edge research will be important for clinicians, researchers, policymakers, and women with primary dysmenorrhea. The knowledge gained from the proposed study will be useful for researchers when designing future studies to identify the mediators of pain interventions for clinical improvements, which could themselves be the target of future interventions. The findings of the proposed study will inform decision-makers regarding the extent to which existing or standard and potential interventions can improve population health (effectiveness) and the resources required to implement these interventions (costs).
    Detailed Description
    Objectives: (1): To evaluate the effectiveness of high-intensity aerobic training (HIAT) on pain intensity, absenteeism, and academic performance among university students with primary dysmenorrhea. (2): To investigate the physiological mechanism(s) underlying aerobic exercise-induced analgesia in women with primary dysmenorrhea. (3) Compare the cost-effectiveness of HIAT against that for usual care to treat pain associated with primary dysmenorrhea. Design and subjects: A mixed-methods study, including a cross-over RCT, and semi-structured focus groups, alongside economic evaluation, will be conducted using 130 women with primary dysmenorrhea. Interventions: Women will randomly allocated into high-intensity aerobic training (HIAT) or wait-list control (WLC) groups. Participants in the HIAT group will receive supervised treadmill training for the first 12 weeks of the trial. Following a four-week washout period the cross-over period will begin during Week 16, and the participants initially randomised to the WLC group will receive the HIAT regimen from Weeks 14-28. Participants initially randomized to HIAT group will be instructed not to engage in exercise during the remainder of the study period (i.e. Weeks 14-28). Outcome measures: Pain intensity, absenteeism from university, academic performance, concentration, dysmenorrhea daily diary, and salivary progesterone and prostaglandin F2-alpha levels in saliva. The EQ-5D-3L will be used to determine the QoL for the HIAT and WLC groups. Data analysis plan: A preliminary test using the independent samples t-test and a two-sided Student's unpaired t-test will be performed to rule out carryover effects and identify the within-participant differences in outcome variables between the study periods, respectively. Treatment effects will be evaluated using an ANOVA with a mixed-effects model considering the longitudinal repeated measures, including the effects of time within each study group and the interaction between time and intervention. The mediation effects will be assessed using the Sobel test. The EQ-5D responses will be converted into utility scores to estimate the gain or loss of quality-adjusted life-years (QUALYs). The seemingly unrelated regression (SUR) analyses will be used to estimate the total cost differences (ΔC) and effect differences (ΔE). Qualitative data will be analysed using the process of thematic analysis.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Primary Dysmenorrhea
    Keywords
    Dysmenorrhea, Primary dysmenorrhea, Pain, Absenteeism, Academic performance

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Masking
    Care ProviderInvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    130 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    High-intensity aerobic training (HIAT)
    Arm Type
    Experimental
    Arm Description
    Women will perform treadmill-based aerobic exercise for three days a week, at 70%-85% of MHR for 30 minutes and perceived exertion of 14-16, based on the Borg RPE scale. This range39 is considered to represent HIAT. Aerobic training will be preceded by warm-up exercises for 10 minutes and followed by cool-down exercises for 10 minutes, at a perceived exertion of 11.0 (Borg RPE).
    Arm Title
    Wait-list control (WLC)
    Arm Type
    Active Comparator
    Arm Description
    Women in the wait-list control group will be instructed to continue with their usual activities and manage their pain as normal (i.e., with analgesics).
    Intervention Type
    Behavioral
    Intervention Name(s)
    High-intensity aerobic training
    Intervention Description
    Women will perform treadmill-based aerobic exercise for three days a week, at 70%-85% of MHR for 30 minutes and perceived exertion of 14-16, based on the Borg RPE scale. This range39 is considered to represent HIAT. Aerobic training will be preceded by warm-up exercises for 10 minutes and followed by cool-down exercises for 10 minutes, at a perceived exertion of 11.0 (Borg RPE).
    Intervention Type
    Behavioral
    Intervention Name(s)
    Wait-list control
    Intervention Description
    Women in the wait-list control group will be instructed to continue with their usual activities and manage their pain as normal (i.e., with analgesics).
    Primary Outcome Measure Information:
    Title
    Pain intensity
    Description
    Average pain intensity during the last 24 hours during menstruation will be assessed using the 0-10 Numeric Rating Scale, with 0 representing 'No pain' and 10 representing 'Worst imaginable pain'. Higher scores indicate greater pain severity
    Time Frame
    Pre-intervention (baseline, 0 week)
    Title
    Pain intensity
    Description
    Average pain intensity during the last 24 hours during menstruation will be assessed using the 0-10 Numeric Rating Scale, with 0 representing 'No pain' and 10 representing 'Worst imaginable pain'. Higher scores indicate greater pain severity
    Time Frame
    Post-intervention at 12 weeks
    Title
    Pain intensity
    Description
    Average pain intensity during the last 24 hours during menstruation will be assessed using the 0-10 Numeric Rating Scale, with 0 representing 'No pain' and 10 representing 'Worst imaginable pain'. Higher scores indicate greater pain severity
    Time Frame
    Post-intervention at 28 weeks
    Title
    Absenteeism from university
    Description
    A prospective electronic diary will be provided for each participant to record university absenteeism.
    Time Frame
    Pre-intervention (baseline, 0 week)
    Title
    Absenteeism from university
    Description
    A prospective electronic diary will be provided for each participant to record university absenteeism.
    Time Frame
    Post-intervention at 12 weeks
    Title
    Absenteeism from university
    Description
    A prospective electronic diary will be provided for each participant to record university absenteeism.
    Time Frame
    Post-intervention at 28 weeks
    Title
    Academic performance
    Description
    Academic performance will be measured using the self-reported 20-item academic performance questionnaire, which was developed to measure the impacts of menstrual symptoms on academic performance. Greater scores indicate greater severity of primary dysmenorrhea
    Time Frame
    Pre-intervention (baseline, 0 week)
    Title
    Academic performance
    Description
    Academic performance will be measured using the self-reported 20-item academic performance questionnaire, which was developed to measure the impacts of menstrual symptoms on academic performance. Greater scores indicate greater severity of primary dysmenorrhea
    Time Frame
    Post-intervention at 12 weeks
    Title
    Academic performance
    Description
    Academic performance will be measured using the self-reported 20-item academic performance questionnaire, which was developed to measure the impacts of menstrual symptoms on academic performance. Greater scores indicate greater severity of primary dysmenorrhea
    Time Frame
    Post-intervention at 28 weeks
    Title
    Progesterone levels
    Description
    Salivary levels of progesterone.
    Time Frame
    Pre-intervention (baseline, 0 week)
    Title
    Progesterone levels
    Description
    Salivary levels of progesterone.
    Time Frame
    Post-intervention at 12 weeks
    Title
    Progesterone levels
    Description
    Salivary levels of progesterone.
    Time Frame
    Post-intervention at 28 weeks
    Title
    Prostaglandin F2-alpha levels
    Description
    Salivary levels of prostaglandin F2-alpha
    Time Frame
    Pre-intervention (baseline, 0 week)
    Title
    Prostaglandin F2-alpha levels
    Description
    Salivary levels of prostaglandin F2-alpha
    Time Frame
    Post-intervention at 12 weeks
    Title
    Prostaglandin F2-alpha levels
    Description
    Salivary levels of prostaglandin F2-alpha
    Time Frame
    Post-intervention at 28 weeks
    Secondary Outcome Measure Information:
    Title
    Concentration
    Description
    The 0-10 visual analogue scale will be used to measure the impact of dysmenorrhea on concentration, with 0 representing 'No difficulty concentrating' and 10 representing 'Maximum difficulty concentrating'.
    Time Frame
    Pre-intervention (baseline, 0 week)
    Title
    Concentration
    Description
    The 0-10 visual analogue scale will be used to measure the impact of dysmenorrhea on concentration, with 0 representing 'No difficulty concentrating' and 10 representing 'Maximum difficulty concentrating'.
    Time Frame
    Post-intervention at 12 weeks
    Title
    Concentration
    Description
    The 0-10 visual analogue scale will be used to measure the impact of dysmenorrhea on concentration, with 0 representing 'No difficulty concentrating' and 10 representing 'Maximum difficulty concentrating'.
    Time Frame
    Post-intervention at 28 weeks
    Title
    Dysmenorrhea daily diary
    Description
    dysmenorrhea. A higher score indicates worse pain.
    Time Frame
    Pre-intervention (baseline, 0 week)
    Title
    Dysmenorrhea daily diary
    Description
    The Dysmenorrhea daily diary is a questionnaire to measure the severity of dysmenorrhea. A higher score indicates worse pain.
    Time Frame
    Post-intervention at 12 weeks
    Title
    Dysmenorrhea daily diary
    Description
    dysmenorrhea. A higher score indicates worse pain.
    Time Frame
    Post-intervention at 28 weeks
    Title
    3-level version of EuroQol 5-Dimension
    Description
    The 3-level version of EuroQol 5-Dimension will be used to determine the quality of life. A higher score indicates better quality of life.
    Time Frame
    12 weeks
    Title
    Cost-diary
    Description
    An electronic diary will be used to record cost expenditures in Hong Kong Dollars and work absenteeism
    Time Frame
    12 weeks

    10. Eligibility

    Sex
    Female
    Gender Based
    Yes
    Gender Eligibility Description
    Participant eligibility is based on self-representation of gender identity as female
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    24 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: women in the age group of 18-24 years old; non-pregnant; having regular menstrual cycles with cycle lengths between 24 and 30 days; experiencing an average menstrual pain intensity equal to or greater than 5 on a 0-10 Numerical Rating Scale; and scoring low (< 600 metabolic equivalent tasks [MET]/week) on the short-form of the International Physical Activity Questionnaire. Exclusion Criteria: women using oral contraceptive pills, hormonal therapy, or intrauterine devices; women using over-the counter analgesics during menstruation to treat dysmenorrhea-associated pain and experience no pain relief with those analgesics; and women participating in any formal exercise programme
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Priya Kannan, PhD
    Phone
    3400
    Ext
    3277
    Email
    priya.kannan@polyu.edu.hk
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Priya Kannan, PhD
    Organizational Affiliation
    The Hong Kong Polytechnic Unviersity
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Aerobic Exercise for Primary Dysmenorrhea

    We'll reach out to this number within 24 hrs